HoxC9 Antibodies

Santa Cruz Biotechnology offers a broad range of HoxC9 monoclonal antibodies for advanced research in developmental biology and gene regulation. HoxC9 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). HoxC9 is a member of the homeobox gene family, which plays a critical role in regulating embryonic development and the differentiation of various cell types. HoxC9 functions are essential for proper limb and axial skeleton formation, and alterations in HoxC9 expression have been implicated in several developmental disorders and cancers. Understanding HoxC9 activity is vital for elucidating the mechanisms underlying these biological processes. Researchers worldwide utilize HoxC9 monoclonal antibodies to explore developmental pathways and disease mechanisms. Current studies focusing on HoxC9 continue to reveal new insights into embryonic development and cellular differentiation. Ongoing research with HoxC9 monoclonal antibodies has expanded our understanding of gene regulation in both normal development and pathological conditions. Santa Cruz Biotechnology monoclonal antibodies support the scientific community by enabling precise investigation of HoxC9's role in development and disease progression.